Minor
AT673 Co-administered With Semaglutide · Type 2 Diabetes (T2D) and Overweight or Obesity
Enrollment closed, study ongoing
Antag TherapeuticsPhase 2 NCT07724340 Registry history of NCT07724340 on ClinicalTrials.gov (opens the registry)
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Enrollment closed, study ongoing
Antag TherapeuticsPhase 2 NCT07724340 Registry history of NCT07724340 on ClinicalTrials.gov (opens the registry)
| Phase 2 | 1 |
Diabetes (1) · Obesity (1) · Type 2 Diabetes (1)